ICD-10 Code C90.02 | Multiple myeloma in relapse Symptoms, Diagnosis, Billing

Multiple myeloma in relapse is a hematological malignancy characterized by the proliferation of malignant plasma cells in the bone marrow. This condition is clinically significant as it often leads to complications such as bone lesions, anemia, and renal impairment. The ICD-10 Code C90.02 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat patients experiencing a relapse of this disease.

What is ICD-10 Code C90.02 for Multiple myeloma in relapse?

ICD-10 Code C90.02 specifically denotes Multiple myeloma in relapse, indicating a recurrence of the disease after a period of remission. This code is essential for clinical documentation and billing, as it reflects the patient's current disease status and informs treatment decisions. It is used when a patient presents with symptoms or complications associated with the relapse of multiple myeloma.

ICD-10 Code C90.02 – Clinical Definition and Explanation of Multiple myeloma in relapse

Multiple myeloma in relapse occurs when previously treated plasma cell malignancy re-emerges, often after a period of remission. This condition requires prompt medical attention due to its potential complications and impact on patient quality of life.

Key Clinical Features:

• Recurrent bone pain or lesions
• Elevated serum protein levels
• Anemia and fatigue
• Renal dysfunction
• Hypercalcemia

ICD-10 Code C90.02 for Multiple myeloma in relapse – SOAP Notes & Clinical Use

In SOAP notes, ICD-10 Code C90.02 is utilized to document the patient's symptoms, assessment findings, and treatment plans related to the relapse of multiple myeloma. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code C90.02 for Multiple myeloma in relapse Mean in SOAP Notes?

ICD-10 Code C90.02 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of multiple myeloma in relapse. This code is crucial for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C90.02 – Multiple myeloma in relapse

The management of multiple myeloma in relapse often necessitates hospitalization for intensive treatment and monitoring.

Antibiotic Therapy:

• Bacterial infections may require first-line antibiotics such as ceftriaxone or piperacillin-tazobactam for 7-14 days.
• Alternative options include vancomycin for resistant strains, duration based on culture results.

Supportive Care:

• Pain management with analgesics and bisphosphonates.
• Hydration and renal support as needed.
• Transfusion support for anemia.

Infection Control:

• Implement standard precautions to prevent infection spread.
• Isolate patients with febrile neutropenia during outbreaks.

How to Document Symptoms of Multiple myeloma in relapse (ICD-10 C90.02) in SOAP Notes

Subjective:

• Patient reports increased bone pain and fatigue.
• History of recurrent infections and recent weight loss.
• Patient expresses concern about worsening symptoms.

Objective:

• Physical examination reveals pallor and tenderness over bony prominences.
• Laboratory results show elevated serum creatinine and calcium levels.
• Imaging indicates new lytic lesions in the vertebrae.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Multiple myeloma in relapse (ICD-10 Code C90.02)

Assessment:

• Diagnosis: Multiple myeloma in relapse, severe.
• ICD-10 Code: C90.02.
• Contributing factors include previous treatment history and current symptomatology.

Plan:

• Initiate chemotherapy regimen based on current guidelines.
• Educate patient on symptom management and potential side effects.
• Schedule follow-up appointments for monitoring and adjustment of treatment.

Treatment & Plan Section for ICD-10 Code C90.02 – Multiple myeloma in relapse

• Consider first-line pharmacologic treatments such as bortezomib or lenalidomide.
• Implement non-pharmacologic strategies including nutritional support and physical therapy.
• Monitor patient response through regular laboratory tests and imaging studies.
• Schedule follow-up visits to assess treatment efficacy and adjust as necessary.

Using ICD-10 Code C90.02 for Multiple myeloma in relapse in Billing & SOAP Note Compliance

• Select accurate subcodes based on clinical severity or complications.
• Document symptoms clearly under Subjective (S) and Objective (O) in SOAP notes.
• Ensure treatment plans align with clinical guidelines to support justified billing.
• Only list CPT codes that are commonly billed with ICD-10 Code C90.02 based on standard medical coding practices.

Related ICD-10 Codes Often Used with Multiple myeloma in relapse

• C90.00 – Multiple myeloma, not having achieved remission
• C90.01 – Multiple myeloma in remission

ICD-10 Code C90.02 in Medical Billing and Insurance for Multiple myeloma in relapse

ICD-10 Code C90.02 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings.

Billing Notes:

• Ensure documentation includes detailed patient history and treatment plans to support the claim.
• Use this code in conjunction with appropriate CPT codes for comprehensive billing.
• Verify that all chart elements align with the diagnosis to avoid claim denials.

Common CPT Pairings: